Board approves allotment of shares to promoter Shankar Varadharajan following warrant conversion under SEBI Regulation 30 disclosure
India’s first prospective study finds molecular testing improved diagnostic clarity in 50% of complex sarcoma cases
The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes
The new assay consolidates screening for four major viral threats into a single workflow
Capital infusion to accelerate Earendil’s R&D platform
The global, first-in-human, open-label trial will assess the safety, tolerability, pharmacokinetics, and preliminary anti-tumor activity of TRI-611
The framework introduces 15 consensus terms and definitions grouped across four core dimensions of skin health
Previously, Arexvy was authorized for adults 60 and older, and for those 50–59 with heightened risk
The move comes as China rapidly expands its capabilities in the pharmaceutical sector, particularly in licensing and drug development
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
